NCT07619313
- Conditions
- Adenocarcinoma, Borderline Resectable Pancreatic Ductal Adenocarcinoma, Carcinoma, +18 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Clinical trial condition
Locally Advanced Cholangiocarcinoma
Explore clinical trials studying Locally Advanced Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Locally Advanced Cholangiocarcinoma trial results
Active, not recruiting
Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations
NCT06160752
- Conditions
- Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +24 more
- Locations
-
- University of California San Francisco (UCSF) San Francisco, California, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- The Ohio State University Columbus, Ohio, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma
NCT06178588
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +11 more
- Locations
-
- University of Kansas Cancer Center Kansas City, Kansas, United States